Sigma Planning Corp’s OncoSec Medical Incorporated ONCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-614
Closed -$29K 1511
2021
Q3
$29K Hold
614
﹤0.01% 1361
2021
Q2
$38K Sell
614
-45
-7% -$4.08K ﹤0.01% 1403
2021
Q1
$69K Sell
659
-832
-56% -$114K ﹤0.01% 1300
2020
Q4
$212K Sell
1,491
-523
-26% -$55.8K 0.01% 1075
2020
Q3
$150K Sell
2,014
-182
-8% -$14.2K 0.01% 991
2020
Q2
$99K Buy
2,196
+946
+76% +$40.3K ﹤0.01% 1003
2020
Q1
$35K Buy
+1,250
New +$46.7K ﹤0.01% 890

Other funds holding ONCS

Sigma Planning Corp's ONCS Position: Q4 2021 in Review

Sigma Planning Corp sold out of OncoSec Medical Incorporated (ONCS) in Q4 2021, closing a stake of 614 shares — an estimated $29K sold.

Sigma Planning Corp first reported a position in ONCS in Q1 2020 and held it in 7 quarters. The position peaked at $212K in Q4 2020. 34 funds tracked by Wall St. Rank hold ONCS as of Q4 2021.

  • Sigma Planning Corp reported no remaining OncoSec Medical Incorporated position as of Q4 2021 after selling out during the quarter.
  • Sigma Planning Corp sold 614 OncoSec Medical Incorporated shares in Q4 2021, an estimated $29K.
  • Sigma Planning Corp first reported a position in OncoSec Medical Incorporated in Q1 2020 and held it in 7 quarters.
  • Sigma Planning Corp's OncoSec Medical Incorporated position peaked at $212K in Q4 2020.
  • 34 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q4 2021.

Based on Sigma Planning Corp's 13F filing for Q4 2021, filed 2 Feb 2022.